当前位置:首页 - 行情中心 - 亿帆医药(002019) - 财务分析

亿帆医药

(002019)

  

流通市值:84.34亿  总市值:121.76亿
流通股本:8.43亿   总股本:12.16亿

亿帆医药(002019)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.96亿元,每股收益0.09元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益876096.12万元,未分配利润485561.87万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产1284526.46万元,负债408430.35万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入1,255,507,032.815,132,949,329.533,922,709,366.042,635,110,083.18
营业总成本1,119,394,963.514,696,113,393.723,507,090,512.562,316,453,207.97
其他经营收益
营业利润120,067,266.08428,644,889.8435,706,848.84342,945,947.22
利润总额120,862,479.85423,704,237.46434,810,968.73344,324,147.92
净利润95,712,723.84373,451,729.24360,252,018.99284,158,135.82
每股收益
其他综合收益-45,377,158.229,928,782.6240,735,013.0361,055,565.28
综合收益总额50,335,565.64403,380,511.86400,987,032.02345,213,701.1
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计3,867,192,019.033,921,887,791.244,313,556,790.113,967,724,843.29
非流动资产:
非流动资产合计8,978,072,598.738,923,116,422.458,792,601,286.988,706,415,052.41
资产总计12,845,264,617.7612,845,004,213.6913,106,158,077.0912,674,139,895.7
流动负债:
流动负债合计2,891,988,690.223,033,045,515.323,401,229,033.153,032,692,512.76
非流动负债:
非流动负债合计1,192,314,763.151,100,973,007.83996,514,670.64984,719,837.9
负债合计4,084,303,453.374,134,018,523.154,397,743,703.794,017,412,350.66
所有者权益(或股东权益):
归属于母公司股东权益合计8,895,654,773.768,834,531,174.798,831,073,964.258,771,392,564.72
股东权益合计8,760,961,164.398,710,985,690.548,708,414,373.38,656,727,545.04
负债和股东权益合计12,845,264,617.7612,845,004,213.6913,106,158,077.0912,674,139,895.7
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计1,367,875,704.745,356,115,263.584,051,201,019.432,774,636,043.07
经营活动现金流出小计1,083,037,4874,897,748,978.753,725,050,032.142,488,538,971.84
经营活动产生的现金流量净额284,838,217.74458,366,284.83326,150,987.29286,097,071.23
投资活动产生的现金流量:
投资活动现金流入小计8,999,530.41105,137,190.1789,640,198.9189,287,620.18
投资活动现金流出小计215,715,287.35559,232,140.2434,009,680.76248,329,030.27
投资活动产生的现金流量净额-206,715,756.94-454,094,950.03-344,369,481.85-159,041,410.09
筹资活动产生的现金流量:
筹资活动现金流入小计361,846,346.491,857,956,837.591,618,903,373.48745,685,562.04
筹资活动现金流出小计359,029,848.981,972,128,315.41,564,916,299.29893,098,804.57
筹资活动产生的现金流量净额2,816,497.51-114,171,477.8153,987,074.19-147,413,242.53
汇率变动对现金及现金等价物的影响-14,429,757.72-3,969,598.42-2,301,795.4515,504,362.21
现金及现金等价物净增加额66,509,200.59-113,869,741.4333,466,784.18-4,853,219.18
期末现金及现金等价物余额730,277,317.06663,768,116.47811,104,642.08772,784,638.72
补充资料:
现金及现金等价物的净增加额--113,869,741.43--4,853,219.18
最新报告期:2026-06-07
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
天风证券杨松,曹文清0.360.470.542026-06-07
中信证券陈竹,王凯旋0.370.460.532026-06-01
首创证券王斌0.380.470.562026-05-20
上海证券张林晚0.410.470.522026-05-15
TOP↑